The Smolka Lab, led by Prof. Marcus Smolka, molecular biology and genetics, recently published a study shedding light on a novel pathway that explains how cancer cells can become resistant to ...
Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances achieved in recent years, resistance to available treatments remains one of the ...
In the evolving landscape of metastatic colorectal cancer, managing patients with RAS/BRAF wild-type tumors remains a ...
Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune ...
Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...
Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...
Merus N.V., an oncology-focused company, announced the publication of research on petosemtamab, a bispecific antibody targeting EGFR and LGR5, in the journal "Cancers." The study highlights the ...
Hair loss is one of the most common and emotionally challenging side effects of chemotherapy, affecting self-esteem, identity, and social confidence. Known as chemotherapy-induced alopecia (CIA), it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results